Friday, 19 April 2024
Lexicon Pharmaceuticals Inc.
-
Overlay
-
Indicators
-
Settings
-
Period
03:15 | 8/3/18
FactsReporter
The company reported its EPS on 12/30/2017. Currently, the stock has a 1 Year Price Target of $22.83. The consensus recommendation, according to Zacks Investment research, is 2.67.
more»
05:30 | 7/3/18
Post Analyst
Optimism reigned on a dull-volume day for Advanced Micro Devices, Inc. (NASDAQ:AMD) which added $0.22 between open and close.
more»
03:42 | 7/3/18
Voice Of Analysts
Moving toward the technical facts, Lexicon Pharmaceuticals, Inc. current distance from 20-Day Simple Moving Average is -2.51% and standing -12.08% away from 50-Day Simple Moving Average while traded -31.45% away from 200-Day Simple Moving Average.
more»
03:03 | 7/3/18
Frisco Fastball
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products for the treatment of human diseases.
more»
06:48 | 6/3/18
Street Observer
Lexicon Pharmaceuticals, Inc. (LXRX) stock price moved with surging change along with the volume 0.78 million shares in Friday trading session.
more»
04:45 | 6/3/18
StockNewsGazette
Recent insider trends for Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) have caught the attention of investors. Insider activity is often a strong indicator of future performance in a stock, and if the data on LXRX is anything to go by, investors should ...
more»
04:00 | 6/3/18
Jonesboro Recorder
Some individual investors may rely heavily on Wall Street analyst opinions when conducting their own stock research. Focusing in on shares of Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX), we have seen that the average broker rating is currently 2.67 ...
more»
03:03 | 6/3/18
Stocks Gallery
Shares of Lexicon Pharmaceuticals, Inc. (LXRX) moved 4.78% in the recent trading day. Last trading transaction put the stock price at $8.55.
more»
11:30 | 2/3/18
Equities.com
Lexicon Pharmaceuticals Inc. (LXRX) had a rough trading day for Thursday March 01 as shares tumbled 5.45%, or a loss of $-0.47 per share, to close at $8.16.
more»
Take Note: Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) has hit some technical weakness in its momentum, and while it has not broken down all the way through support -- watch the key levels that we discuss below and further, watch the stochastics and ...
more»